• Panacea Global, Inc. (PGI) is a biotechnology company focusing on developing and commercializing products for the early detection, diagnosis and monitoring the recurrence of cancer. Panacea’s novel product is a blood test that can detect the presence of cancer in humans using a novel cancer biomarker named Human Aspartyl (Asparaginyl) B-Hydroxylase (HAAH), an enzyme which is over expressed in cancer cells and is the foundation of our breakthrough technology.

Stock Quotes

PANG0.70  chart+0.02

MISSION:
The company’s lead program is to provide accurate, timely, cost effective and non-invasive testing across the globe to increase the quality of life of patients and ultimately saving lives.


VISION:
Our vision is to have our diagnostics be affordable and accessible worldwide, and to provide accurate diagnostics for all forms of cancer.


Latest News